Results 101 to 110 of about 7,531,846 (135)
Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are characterized by skin photosensitivity caused by accumulation of protoporphyrin IX. We aimed to review the clinical evidence of efficacy and safety of skin photosensitivity treatments in individuals with EPP or XLP. We systematically searched MEDLINE, Embase, the Cochrane Library,
Ida M Heerfordt, Peter A Philipsen
exaly +5 more sources
Annular Elastolytic Giant Cell Granuloma Associated to Late-Onset X-Linked Dominant Protoporphyria
X-linked dominant protoporphyria (XLDPP) is a genetic disorder that affects the synthesis of the heme group due to an increase in delta-aminolaevulinate synthase 2 (ALAS2) enzyme activity. Moreover, annular elastolytic giant-cell granuloma (AEGCG) is a rare reactive granulomatous dermatosis, usually associated with actinic damage.
Marta Santamariña +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
X‐linked dominant protoporphyria: The first reported Japanese case
The Journal of Dermatology, 2015AbstractA 12‐year‐old boy with photosensitivity since 3 years of age presented with small concavities on both cheeks, the nasal root and the dorsal surface of both hands. According to the clinical features, erythropoietic protoporphyria (EPP) was suspected.
Yukiko, Ninomiya +5 more
openaire +2 more sources
PD01 First UK report of pregnancy and childbirth in X-linked erythropoietic protoporphyria
British Journal of Dermatology, 2023Abstract X-linked erythropoietic protoporphyria (XLEPP), an exceptionally rare form of cutaneous porphyria, is characterized by significant acute painful photosensitivity and a risk of both reduced bone mineral density and protoporphyric hepatopathy that may progress to liver failure.
Danja Schulenburg-Brand +4 more
openaire +1 more source
British Journal of Dermatology, 2023
Abstract Erythropoietic protoporphyria (EPP) is usually caused by autosomal dominant mutations in FECH: raised protoporphyrin levels cause itching, burning and erythema after sun exposure, with facial scarring and sometimes liver damage.
Sahana Srinivas, Celia Moss
openaire +1 more source
Abstract Erythropoietic protoporphyria (EPP) is usually caused by autosomal dominant mutations in FECH: raised protoporphyrin levels cause itching, burning and erythema after sun exposure, with facial scarring and sometimes liver damage.
Sahana Srinivas, Celia Moss
openaire +1 more source
Mutations in the C-terminus of human erythroid 5-aminolevulinate synthase (hALAS2), a pyridoxal 5′-phosphate (PLP)-dependent enzyme, are associated with two different blood disorders, X-linked sideroblastic anemia (XLSA) and X-linked protoporphyria (XLPP)
Gloria Cruz Ferreira +2 more
exaly +2 more sources
Blood
Background: Erythropoietic protoporphyria and X-linked protoporphyria (collectively referred to as EPP) are rare, genetic disorders of the heme biosynthetic pathway, leading to accumulation of the photoactive metabolite protoporphyrin IX (PPIX).
Hetanshi Naik +7 more
openaire +1 more source
Background: Erythropoietic protoporphyria and X-linked protoporphyria (collectively referred to as EPP) are rare, genetic disorders of the heme biosynthetic pathway, leading to accumulation of the photoactive metabolite protoporphyrin IX (PPIX).
Hetanshi Naik +7 more
openaire +1 more source
Diffuse 18F-FDG Avidity in Liver Associated With X-Linked Protoporphyria on PET/CT
Clinical Nuclear Medicine, 2018Abstract An 18F-FDG PET/CT was performed on a 43-year-old woman with photosensitive skin rash, abnormal liver function, and pancytopenia, which demonstrated prominent hepatomegaly, splenomegaly, and diffuse liver 18F-FDG avidity. The liver biopsy revealed intrahepatic cholestasis with biliary fibrosis resulting from the deposition of ...
Zhanli, Fu +4 more
openaire +2 more sources
Bone marrow transplant for
AbstractXLP is an erythroid porphyria that results in variable cutaneous photosensitivity due to accumulation of protoporphyrin. The genetic defect in XLP is mutation of the gene ALAS2, resulting in gain of function for the erythroid enzyme 5‐aminolevulinate synthase 2.
David F, Butler +6 more
openaire +2 more sources
Clinical and Experimental Dermatology
We read with interest the phase II BEACON study by Ross et al. on biopterin for erythropoietic protoporphyria (EPP). While the observed PPIX reductions are encouraging, several unaddressed methodological issues undermine the validity of the efficacy conclusions.
Zhenzhen Xiao, Rui Li, Yingjian Tan
openaire +1 more source
We read with interest the phase II BEACON study by Ross et al. on biopterin for erythropoietic protoporphyria (EPP). While the observed PPIX reductions are encouraging, several unaddressed methodological issues undermine the validity of the efficacy conclusions.
Zhenzhen Xiao, Rui Li, Yingjian Tan
openaire +1 more source

